Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity
Antoni Vilaseca, Giuliano Guglielmetti, Emily A Vertosick, Daniel D Sjoberg, Angelica Grasso, Nicole E Benfante, Daniel P Nguyen, Renato B Corradi, Jonathan Coleman, Paul Russo, Andrew J Vickers, Karim A Touijer, Antoni Vilaseca, Giuliano Guglielmetti, Emily A Vertosick, Daniel D Sjoberg, Angelica Grasso, Nicole E Benfante, Daniel P Nguyen, Renato B Corradi, Jonathan Coleman, Paul Russo, Andrew J Vickers, Karim A Touijer
Abstract
Background: Indications for partial nephrectomy (PN) have expanded to include larger tumors. Compared with radical nephrectomy (RN), PN reduces the risk of chronic kidney disease but is associated with higher morbidity.
Objective: To explore whether the benefit of PN (preservation of estimated glomerular filtration rate [eGFR] ≥60ml/min/1.73m2 1yr postoperatively) over RN is offset by higher morbidity for cT2-cT3a tumors.
Design, setting, and participants: A total of 1921 patients with renal cortical tumors who underwent nephrectomy between 2000 and 2012 were analyzed, with 297 having clinical stage T2 or higher disease.
Outcome measurements and statistical analysis: Multivariable logistic regression models adjusted for age, tumor size, and comorbidities were used to calculate the risk of complications within 90d and the risk of low eGFR across a range of tumor sizes. Models were created separately for RN and PN, and the difference between risk estimates was calculated.
Results and limitations: For tumors with diameters between 7 and 12cm, the risk of eGFR downgrade associated with RN was higher than the risk of complications associated with PN. The magnitude of the risk of eGFR downgrade was similar to the magnitude of complications risk across all tumor sizes. Our analysis was performed at a single institution, and used only tumor size to compare the risk and benefits of surgery.
Conclusions: Our study suggests that PN is associated with higher eGFR preservation than RN for cT2 or greater renal tumors. The magnitude of this advantage offsets the higher morbidity observed with PN.
Patient summary: When treating a large kidney tumor, it is difficult to decide whether it is better to remove the whole kidney or remove just the tumor. The second option improves postoperative renal function but is more complex. We tried to find whether there is a tumor size at which one technique should be used over the other.
Keywords: Chronic kidney disease; Complications; Nephrectomy; Nephron-sparing surgery; Renal cell carcinoma.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Figures
![Fig. 1 –](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8407532/bin/nihms-1706675-f0001.jpg)
![Fig. 2 –](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8407532/bin/nihms-1706675-f0002.jpg)
![Fig. 3 –](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8407532/bin/nihms-1706675-f0003.jpg)
Fig. 3 –
Difference in risk differences…
Fig. 3 –
Difference in risk differences by tumor size, with 95% confidence interval, for…
- Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R. Mir MC, et al. Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7. Eur Urol. 2017. PMID: 27614693 Review.
- Predicting Renal Function Outcomes After Partial and Radical Nephrectomy.Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Bhindi B, et al. Eur Urol. 2019 May;75(5):766-772. doi: 10.1016/j.eururo.2018.11.021. Epub 2018 Nov 23. Eur Urol. 2019. PMID: 30477983
- Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.Takagi T, Kondo T, Omae K, Iizuka J, Kobayashi H, Yoshida K, Hashimoto Y, Tanabe K. Takagi T, et al. Int Urol Nephrol. 2016 Sep;48(9):1421-7. doi: 10.1007/s11255-016-1317-9. Epub 2016 May 18. Int Urol Nephrol. 2016. PMID: 27193433
- Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.An JY, Ball MW, Gorin MA, Hong JJ, Johnson MH, Pavlovich CP, Allaf ME, Pierorazio PM. An JY, et al. Urology. 2017 Feb;100:151-157. doi: 10.1016/j.urology.2016.10.047. Epub 2016 Nov 23. Urology. 2017. PMID: 27889493 Free PMC article.
- Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses.Kim SP, Campbell SC, Gill I, Lane BR, Van Poppel H, Smaldone MC, Volpe A, Kutikov A. Kim SP, et al. Eur Urol. 2017 Jul;72(1):64-75. doi: 10.1016/j.eururo.2016.11.038. Epub 2016 Dec 14. Eur Urol. 2017. PMID: 27988238 Review.
- Patient Factors Impacting Perioperative Outcomes for T1b-T2 Localized Renal Cell Carcinoma May Guide Decision for Partial versus Radical Nephrectomy.Shah YB, Simhal RK, Wang KR, Goldberg H, Lallas CD, Chandrasekar T. Shah YB, et al. J Clin Med. 2022 Dec 26;12(1):175. doi: 10.3390/jcm12010175. J Clin Med. 2022. PMID: 36614976 Free PMC article.
- Associations between tumor grade, contrast-enhanced ultrasound features, and microvascular density in patients with clear cell renal cell carcinoma: a retrospective study.Meng X, Yang R, Zhao S, Sun Z, Wang H. Meng X, et al. Quant Imaging Med Surg. 2022 Mar;12(3):1882-1892. doi: 10.21037/qims-21-291. Quant Imaging Med Surg. 2022. PMID: 35284253 Free PMC article.
- Partial Nephrectomy Versus Radical Nephrectomy for Clinical T2 or Higher Stage Renal Tumors: A Systematic Review and Meta-Analysis.Huang R, Zhang C, Wang X, Hu H. Huang R, et al. Front Oncol. 2021 Jun 10;11:680842. doi: 10.3389/fonc.2021.680842. eCollection 2021. Front Oncol. 2021. PMID: 34178668 Free PMC article.
- Preventive strategies for acute kidney injury in cancer patients.Cosmai L, Porta C, Foramitti M, Perrone V, Mollica L, Gallieni M, Capasso G. Cosmai L, et al. Clin Kidney J. 2020 Nov 28;14(1):70-83. doi: 10.1093/ckj/sfaa127. eCollection 2021 Jan. Clin Kidney J. 2020. PMID: 33564407 Free PMC article. Review.
- Laparoscopic cytoreductive nephrectomy and adrenalectomy for metachronous RCC metastases-Case report.Petrut B, Bujoreanu CE, Hardo VV, Barbos A, Fetica B. Petrut B, et al. Int J Surg Case Rep. 2020;74:268-272. doi: 10.1016/j.ijscr.2020.08.046. Epub 2020 Aug 29. Int J Surg Case Rep. 2020. PMID: 32911447 Free PMC article.
- Comparative Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Aged
- Female
- Glomerular Filtration Rate
- Humans
- Kidney / physiology
- Kidney Neoplasms / pathology
- Kidney Neoplasms / surgery*
- Male
- Middle Aged
- Morbidity
- Neoplasm Staging
- Nephrectomy / methods*
- Postoperative Complications / epidemiology*
- Prospective Studies
- Risk Assessment
- Full Text Sources
- Medical
- Research Materials
- Miscellaneous
![Fig. 3 –](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8407532/bin/nihms-1706675-f0004.jpg)
Source: PubMed